PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.
Gabryś HS, Basler L, Burgermeister S, Hogan S, Ahmadsei M, Pavic M, Bogowicz M, Vuong D, Tanadini-Lang S, Förster R, Kudura K, Huellner M, Dummer R, Levesque MP, Guckenberger M.
Gabryś HS, et al. Among authors: levesque mp.
Front Oncol. 2022 Nov 24;12:977822. doi: 10.3389/fonc.2022.977822. eCollection 2022.
Front Oncol. 2022.
PMID: 36505821
Free PMC article.